Corbus Pharmaceuticals (CRBP) Insider Trading & Ownership $17.47 +0.74 (+4.42%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Corbus Pharmaceuticals (NASDAQ:CRBP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.00%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$40.38 MNumber OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$2.53 M Get CRBP Insider Trade Alerts Want to know when executives and insiders are buying or selling Corbus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CRBP Insider Buying and Selling by Quarter Ad Darwin2025: Digital Asset Insights You Need to KnowCryptocurrencies are taking off again, and those in-the-know are positioning themselves to ride this wave in 2025. The question is—will you be one of them? With explosive growth on the horizon, there’s never been a better time to understand the potential gains in crypto. Our guide, Navigating the Future: Cryptos to Watch in 2025, reveals the cryptos leading this surge and the strategies to maximize your profit potential.Get your guide today! Corbus Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/20/2024Cormorant Asset Management, LpMajor ShareholderBuy350,000$20.01$7,003,500.00 6/18/2024Sean F MoranCFOSell1,958$42.12$82,470.96 6/17/2024Yuval CohenCEOSell11,103$46.02$510,960.06 6/14/2024Sean F MoranCFOSell9,355$49.87$466,533.85 6/14/2024Yuval CohenCEOSell29,317$50.17$1,470,833.89 3/7/2024Cormorant Asset Management, LpMajor ShareholderBuy250,000$40.05$10,012,500.00 2/2/2024Cormorant Asset Management, LpMajor ShareholderBuy750,000$19.00$14,250,000.00 1/26/2024Cormorant Asset Management, LpMajor ShareholderBuy282,632$32.24$9,112,055.68 (Data available from 1/1/2013 forward) CRBP Insider Trading Activity - Frequently Asked Questions Who is on Corbus Pharmaceuticals's Insider Roster? The list of insiders at Corbus Pharmaceuticals includes Cormorant Asset Management, Lp, Craig Stuart Millian, Sean F Moran, and Yuval Cohen. Learn more on insiders at CRBP. What percentage of Corbus Pharmaceuticals stock is owned by insiders? 4.00% of Corbus Pharmaceuticals stock is owned by insiders. Learn more on CRBP's insider holdings. Which Corbus Pharmaceuticals insiders have been buying company stock? The following insider purchased CRBP shares in the last 24 months: Cormorant Asset Management, Lp ($40,378,055.68). How much insider buying is happening at Corbus Pharmaceuticals? Insiders have purchased a total of 1,632,632 CRBP shares in the last 24 months for a total of $40,378,055.68 bought. Which Corbus Pharmaceuticals insiders have been selling company stock? The following insiders have sold CRBP shares in the last 24 months: Sean F Moran ($549,004.81), and Yuval Cohen ($1,981,793.95). How much insider selling is happening at Corbus Pharmaceuticals? Insiders have sold a total of 51,733 Corbus Pharmaceuticals shares in the last 24 months for a total of $2,530,798.76 sold. Corbus Pharmaceuticals Key ExecutivesDr. Yuval Cohen Ph.D. (Age 49)CEO & Director Compensation: $907.78kMr. Sean F. Moran CPA (Age 66)M.B.A., Chief Financial Officer Compensation: $609.28k2 recent tradesMs. Lindsey SmithHead of Corporate Communications & Patient AdvocacyMs. Christina BertschHead of Human ResourcesDr. Dominic Smethurst M.A. (Age 49)M.D., Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies Tonix Pharmaceuticals Insider Transactions Cronos Group Insider Transactions Pliant Therapeutics Insider Transactions Kura Oncology Insider Transactions Tyra Biosciences Insider Transactions Prothena Insider Transactions Relay Therapeutics Insider Transactions Anavex Life Sciences Insider Transactions Replimune Group Insider Transactions Erasca Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:CRBP) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corbus Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Corbus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
